[ Price : $8.95]
Novo Nordisk says data from its landmark Phase 3 SELECT cardiovascular outcomes trial assessing the effects of once-weekly Wegovy ...[ Price : $8.95]
FDA clears an InMed.AI 510(k) for NeuroShield, which the company describes as an automated brain geometry-based quantifying analyt...[ Price : $8.95]
FDA approves a Pacira BioSciences supplemental NDA to expand Exparels (bupivacaine liposome injectable suspension) label to includ...[ Price : $8.95]
FDA gives Brixton Biosciences a breakthrough device designation for its Coolio Therapy, which is intended to deliver long-lasting ...[ Price : $8.95]
Based on recent disappointing study data, Neurocrine Biosciences says it is stopping the development of two drugs being evaluated ...[ Price : $8.95]
Federal Register notice: FDA announces an 11/29 advisory committee meeting to discuss multi-cancer detection IVDs.[ Price : $8.95]
The Puerto Rico federal court enters a consent decree requiring Droguera Betances, one of the territorys largest pharmaceutical di...[ Price : $8.95]
A BMJ investigation raises concerns that the federal governments vaccine adverse event system is not operating as planned and safe...